NORTHWEST BIOTHERAPEUTICS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Northwest Biotherapeutics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Northwest Biotherapeutics Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.29B shares, a 12.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.29B +141M +12.3% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.23B +115M +10.3% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 1.2B +112M +10.4% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 1.18B +107M +10% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 1.15B +1.15B Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.12B +80.7M +7.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 1.08B +113M +11.7% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.07B +120M +12.7% Dec 31, 2022 10-K 2024-03-05
Q3 2022 1.05K* -892M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 1.03B +177M +20.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 970M +127M +15.1% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 948M +119M +14.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 892M +112M +14.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 857M +135M +18.7% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 842M +180M +27.2% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 830M +215M +35% Dec 31, 2020 10-K 2022-03-01
Q3 2020 780M +197M +33.8% Sep 30, 2020 10-Q 2021-01-15
Q2 2020 722M +160M +28.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 662M +125M +23.3% Mar 31, 2020 10-Q 2020-06-24
Q4 2019 614M +91.1M +17.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 583M +72.7M +14.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 563M +118M +26.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 537M +122M +29.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 523M +194M +59.1% Dec 31, 2018 10-K 2020-03-16
Q3 2018 510M +200M +64.7% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 445M +207M +87.3% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 415M +229M +124% Mar 31, 2018 10-Q 2018-05-16
Q4 2017 329M +172M +109% Dec 31, 2017 10-K 2019-04-02
Q3 2017 310M +189M +156% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 237M +131M +124% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 186M +83.8M +82.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 157M +61.1M +63.8% Dec 31, 2016 10-K 2018-04-17
Q3 2016 121M +42.6M +54.5% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 106M +28.4M +36.6% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 102M +31.4M +44.7% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 95.9M +26.9M +39% Dec 31, 2015 10-K 2017-04-17
Q3 2015 78.2M +16M +25.6% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 77.7M +18.9M +32.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 70.3M +15.5M +28.3% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 69M +23.3M +51% Dec 31, 2014 10-K 2016-03-16
Q3 2014 62.2M +25.6M +69.8% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 58.8M +28M +91.3% Jun 30, 2014 10-Q 2014-08-15
Q1 2014 54.8M +27.7M +102% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 45.7M +21M +85.1% Dec 31, 2013 10-K 2015-03-17
Q3 2013 36.6M +24.8M +210% Sep 30, 2013 10-Q 2013-11-15
Q2 2013 30.7M -135M -81.4% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 27.1M -132M -83% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 24.7M +15.3M +164% Dec 31, 2012 10-K 2014-04-01
Q3 2012 11.8M -85.3M -87.8% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 165M +71.9M +77% Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 159M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 9.33M -63.8M -87.2% Dec 31, 2011 10-K 2013-04-08
Q3 2011 97.1M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 93.4M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 73.1M Dec 31, 2010 10-K 2012-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.